AMAL Therapeutics raises CHF 33.2 Million Series B Round
AMAL Therapeutics SA , a Swiss biotech developing peptide-based therapeutic cancer vaccines, announces that it has completed the second closing of its Series B...
AMAL Therapeutics raises CHF 33.2 Million Series B Round
AMAL Therapeutics SA , a Swiss biotech developing peptide-based therapeutic cancer vaccines, announces that it has completed the second closing of its Series B...
T3 Pharmaceuticals Wins Prestigious Falling Walls Venture Award for Its Bacterial Cancer Therapy
T3 Pharmaceuticals , a biotech company with a focus on immuno-oncology, announced it has been named “2018 Science Start-Up of the Year” by Falling...
Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure
Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, announced that it has initiated enrollment of patients into a first-in-human clinical...
SIRIO Pharma opens multimillion gummy production plant at new high-tech nutraceutical facility in Ma’anshan, China
Sirio Pharma Co. Ltd – the global nutraceutical contract development and manufacturing organization (CDMO) announces the opening of a gummy production workshop plant at...
FDA Approves First Drug Using the Recombinant Factor C Assay for Endotoxin Testing
Lonza announced that the recombinant Factor C Assay has been used for endotoxin testing of Eli Lilly’s Emgality™ , the first drug approved by...
European Commission has granted Marketing Authorization for Vertex’s SYMKEVI
Vertex Pharmaceuticals Limited, announced that the European Commission has granted Marketing Authorization for SYMKEVI in a combination regimen with ivacaftor for the treatment of...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...